Clinical trials
Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in the Philippines
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Merck Sharp & Dohme LLC | 3 |
| ArriVent BioPharma, Inc. | 1 |
| Prestige Biopharma Limited | 1 |
| Samsung Bioepis Co., Ltd. | 1 |
| Taiho Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 12 |
| Carcinoma | 3 |
| Lung Diseases | 1 |
| Lung Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.